dxlink
Forgot your password? français
  • Home
  • An Update on the Safety of Smoking-cessation Therapies
    Robert M. Anthenelli, M.D.
  • Program Evaluation
Herpes Zoster banner
Presenter
Robert M. Anthenelli, M.D.
Professor and Executive Vice Chair
Director, Pacific Treatment and Research Center
Department of Psychiatry
University of California, San Diego, Health Sciences
Learning Objectives

After viewing this program, you will be able to:
  • Describe the objectives, design, and main findings of a recent study on the safety of smoking-cessation therapies.
  • Evaluate the benefits and risks associated with smoking-cessation therapies.
  • Provide evidence-based recommendations to patients who aim to quit smoking.
Disclosure

Funded through an educational grant from Pfizer Canada Inc.

Thank you for submitting the program evaluation.

  • An Update on the Safety of Smoking-cessation Therapies

    Program Evaluation:

  • Max number of characters 500
  • Yes
    		 No
    Max number of characters 500
  • Max number of characters 500
  • Max number of characters 500
  • Yes No
    Max number of characters 500
  • Max number of characters 500
The information and opinions contained herein reflect the views and experience of the authors and not necessarily those of the sponsors or STA Communications Inc. It is recommended that physicians evaluate their patient’s individual conditions before making a diagnosis or treatment decision. Any products mentioned herein should be used in accordance with the prescribing information contained in their respective product monographs. The content on this site is intended for health professionals. Copyright 2024 STA Communications Inc. All rights reserved. Content on this site may not be reproduced without explicit consent from the sponsor and STA Communications Inc. Terms and Conditions | Privacy Policy